Industry: Chemical & Material
Published Date: 2024-06-17
Pages: 116 Pages
Report ld: 3197759
Request Sample
Customized Report
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
The global Ertapenem Sodium revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In Japan the Ertapenem Sodium revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and Japan Ertapenem Sodium market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Ertapenem Sodium include Tecoland, Qilu Pharmaceutical, Gland Pharma, Sun Pharma, Zhejiang New Donghai Pharmaceutical, Savior Lifetec Corporation, Aurobindo, CSPC, etc. The global five biggest players hold a share of % in 2023.
Ertapenem Sodium market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Ertapenem Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For Japan market, this report focuses on the Ertapenem Sodium market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in Japan.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Ertapenem Sodium definition, global sales (volume and revenue), Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Ertapenem Sodium companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Ertapenem Sodium in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ertapenem Sodium sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Ertapenem Sodium Product Introduction
1.2 Global Ertapenem Sodium Outlook 2019 VS 2023 VS 2030
1.2.1 Global Ertapenem Sodium Sales in US$ Million for the Year 2019-2030
1.2.2 Global Ertapenem Sodium Sales in Volume for the Year 2019-2030
1.3 Japan Ertapenem Sodium Outlook 2019 VS 2023 VS 2030
1.3.1 Japan Ertapenem Sodium Sales in US$ Million for the Year 2019-2030
1.3.2 Japan Ertapenem Sodium Sales in Volume for the Year 2019-2030
1.4 Ertapenem Sodium Market Size, Japan VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of Japan Ertapenem Sodium in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Ertapenem Sodium Market Size, Japan VS Global, 2019 VS 2023 VS 2030
1.5 Ertapenem Sodium Market Dynamics
1.5.1 Ertapenem Sodium Industry Trends
1.5.2 Ertapenem Sodium Market Drivers
1.5.3 Ertapenem Sodium Market Challenges
1.5.4 Ertapenem Sodium Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Ertapenem Sodium by Type
2.1 Ertapenem Sodium Market by Type
2.1.1 Purity≥98%
2.1.2 Purity≥99%
2.2 Global Ertapenem Sodium Market Size by Type
2.2.1 Global Ertapenem Sodium Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Ertapenem Sodium Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Ertapenem Sodium Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 Japan Ertapenem Sodium Market Size by Type
2.3.1 Japan Ertapenem Sodium Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 Japan Ertapenem Sodium Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 Japan Ertapenem Sodium Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Ertapenem Sodium by Application
3.1 Ertapenem Sodium Market by Application
3.1.1 Ertapenem Sodium Injection
3.1.2 Other
3.2 Global Ertapenem Sodium Market Size by Application
3.2.1 Global Ertapenem Sodium Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Ertapenem Sodium Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Ertapenem Sodium Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 Japan Ertapenem Sodium Market Size by Application
3.3.1 Japan Ertapenem Sodium Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 Japan Ertapenem Sodium Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 Japan Ertapenem Sodium Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Ertapenem Sodium Competitor Landscape by Company
4.1 Global Ertapenem Sodium Market Size by Company
4.1.1 Global Key Manufacturers of Ertapenem Sodium, Ranked by Revenue (2023)
4.1.2 Global Ertapenem Sodium Revenue by Manufacturer (2019-2024)
4.1.3 Global Ertapenem Sodium Sales by Manufacturer (2019-2024)
4.1.4 Global Ertapenem Sodium Price by Manufacturer (2019-2024)
4.2 Global Ertapenem Sodium Concentration Ratio (CR)
4.2.1 Ertapenem Sodium Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ertapenem Sodium in 2023
4.2.3 Global Ertapenem Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Ertapenem Sodium, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Ertapenem Sodium, Product Offered and Application
4.5 Global Key Manufacturers of Ertapenem Sodium, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 Japan Ertapenem Sodium Market Size by Company
4.7.1 Key Players of Ertapenem Sodium in Japan, Ranked by Revenue (2023)
4.7.2 Japan Ertapenem Sodium Revenue by Players (2019-2024)
4.7.3 Japan Ertapenem Sodium Sales by Players (2019-2024)
5 Global Ertapenem Sodium Market Size by Region
5.1 Global Ertapenem Sodium Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Ertapenem Sodium Market Size in Volume by Region (2019-2030)
5.2.1 Global Ertapenem Sodium Sales in Volume by Region: 2019-2024
5.2.2 Global Ertapenem Sodium Sales in Volume Forecast by Region (2025-2030)
5.3 Global Ertapenem Sodium Market Size in Value by Region (2019-2030)
5.3.1 Global Ertapenem Sodium Sales in Value by Region: 2019-2024
5.3.2 Global Ertapenem Sodium Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Ertapenem Sodium Market Size YoY Growth 2019-2030
6.2 Americas Ertapenem Sodium Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Ertapenem Sodium Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Ertapenem Sodium Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Ertapenem Sodium Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Ertapenem Sodium Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Ertapenem Sodium Market Size YoY Growth 2019-2030
7.2 EMEA Ertapenem Sodium Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Ertapenem Sodium Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Ertapenem Sodium Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Ertapenem Sodium Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Ertapenem Sodium Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Ertapenem Sodium Market Size YoY Growth 2019-2030
8.2 China Ertapenem Sodium Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Ertapenem Sodium Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Ertapenem Sodium Market Size YoY Growth 2019-2030
9.2 APAC Ertapenem Sodium Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Ertapenem Sodium Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Ertapenem Sodium Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Ertapenem Sodium Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Ertapenem Sodium Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Tecoland
10.1.1 Tecoland Company Information
10.1.2 Tecoland Description and Business Overview
10.1.3 Tecoland Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Tecoland Ertapenem Sodium Products Offered
10.1.5 Tecoland Recent Development
10.2 Qilu Pharmaceutical
10.2.1 Qilu Pharmaceutical Company Information
10.2.2 Qilu Pharmaceutical Description and Business Overview
10.2.3 Qilu Pharmaceutical Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Qilu Pharmaceutical Ertapenem Sodium Products Offered
10.2.5 Qilu Pharmaceutical Recent Development
10.3 Gland Pharma
10.3.1 Gland Pharma Company Information
10.3.2 Gland Pharma Description and Business Overview
10.3.3 Gland Pharma Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Gland Pharma Ertapenem Sodium Products Offered
10.3.5 Gland Pharma Recent Development
10.4 Sun Pharma
10.4.1 Sun Pharma Company Information
10.4.2 Sun Pharma Description and Business Overview
10.4.3 Sun Pharma Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Sun Pharma Ertapenem Sodium Products Offered
10.4.5 Sun Pharma Recent Development
10.5 Zhejiang New Donghai Pharmaceutical
10.5.1 Zhejiang New Donghai Pharmaceutical Company Information
10.5.2 Zhejiang New Donghai Pharmaceutical Description and Business Overview
10.5.3 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Products Offered
10.5.5 Zhejiang New Donghai Pharmaceutical Recent Development
10.6 Savior Lifetec Corporation
10.6.1 Savior Lifetec Corporation Company Information
10.6.2 Savior Lifetec Corporation Description and Business Overview
10.6.3 Savior Lifetec Corporation Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.6.4 Savior Lifetec Corporation Ertapenem Sodium Products Offered
10.6.5 Savior Lifetec Corporation Recent Development
10.7 Aurobindo
10.7.1 Aurobindo Company Information
10.7.2 Aurobindo Description and Business Overview
10.7.3 Aurobindo Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.7.4 Aurobindo Ertapenem Sodium Products Offered
10.7.5 Aurobindo Recent Development
10.8 CSPC
10.8.1 CSPC Company Information
10.8.2 CSPC Description and Business Overview
10.8.3 CSPC Ertapenem Sodium Sales, Revenue and Gross Margin (2019-2024)
10.8.4 CSPC Ertapenem Sodium Products Offered
10.8.5 CSPC Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Ertapenem Sodium Industry Chain Analysis
11.2 Ertapenem Sodium Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Ertapenem Sodium Production Mode & Process
11.4 Ertapenem Sodium Sales and Marketing
11.4.1 Ertapenem Sodium Sales Channels
11.4.2 Ertapenem Sodium Distributors
11.5 Ertapenem Sodium Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Ertapenem Sodium market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global Ertapenem Sodium market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 103
USD 3950.00
(Single User License)
The global Ertapenem Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 134
USD 2900.00
(Single User License)
The global Ertapenem Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 143
USD 4900.00
(Single User License)
The global Ertapenem Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 77
USD 4250.00
(Single User License)
The global market for Ertapenem Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 90
USD 2900.00
(Single User License)
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 105
USD 3950.00
(Single User License)
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published Date: 2024-06-17
Pages: 95
USD 3950.00
(Single User License)
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published Date: 2024-06-17
Pages: 148
USD 4900.00
(Single User License)
The global Ertapenem Sodium market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global Ertapenem Sodium market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 103
The global Ertapenem Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 134
The global Ertapenem Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 143
The global Ertapenem Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 77
The global market for Ertapenem Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 90
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 105
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published: 2024-06-17
Pages: 95
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published: 2024-06-17
Pages: 148
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now